Comparative analysis of clinical effectiveness of α1-adrenoblockers doxazosin, tamsulosin and silodosin in males with chronic non-inflammatory prostatitis
- Authors: Lobkarev AO1, Khafiz'yanova RK.2, Lobkarev OA1
-
Affiliations:
- Kazan State Medical Academy
- Kazan State Medical University
- Issue: Vol 99, No 6 (2018)
- Pages: 880-886
- Section: Theoretical and clinical medicine
- URL: https://ogarev-online.ru/kazanmedj/article/view/10500
- DOI: https://doi.org/10.17816/KMJ2018-880
- ID: 10500
Cite item
Full Text
Abstract
Aim. Comparative study of clinical effectiveness of doxazosin, tamsulosin and silodosin as monotherapy for patients with chronic non-inflammatory prostatitis.
Methods. Outpatient medical records (OMR) of patients with the diagnosis of chronic non-inflammatory prostatitis who were treated in “The clinic of ambulatory urology” (Kazan) in 2012-2017, were analyzed: all 173 OMR of patients receiving doxazosin 1 mg QD for 30 days as monotherapy; all 150 OMR of patients receiving doxazosin 2 mg per day BID for 30 days as monotherapy; all 54 OMR of patients receiving doxazosin 4 mg per day BID for 30 days as monotherapy; all 77 OMR of patients receiving tamsulosin 0.4 mg QD for 30 days as monotherapy; all 36 OMR of patients receiving silodosin 8 mg QD for 30 days as monotherapy. Based on these OMR the “Clinical index of chronic prostatitis” (CI CP) was analyzed before the start of pharmacotherapy and 30 days after the beginning. According to the clinical index, the discrete sample was ordered containing the values of CI from 0 points (no complaints) to 50 points (maximal score - the most marked symptoms).
Results. Before the beginning of the treatment every sample of patients is homogeneous and after 30-day treatment they lose homogeneity and tend to divide into several homogeneous samples.
Conclusion. Clinical effectiveness of doxazosin, tamsulosin and silodosin in men with CNP varies in wide range, is poorly predictable, poorly explainable and needs further studies according to the principles of modern evidence-based medicine.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A O Lobkarev
Kazan State Medical Academy
Author for correspondence.
Email: Lobkarev@gmail.com
Kazan, Russia
R Kh Khafiz'yanova
Kazan State Medical University
Email: Lobkarev@gmail.com
Kazan, Russia
O A Lobkarev
Kazan State Medical Academy
Email: Lobkarev@gmail.com
Kazan, Russia
References
- Khafiz’yanova R.Kh., Burykin I.M., Aleeva G.N. Matematicheskaya statistika v eksperimental'noy i klinicheskoy farmakologii. (Mathematical statistics in experimental and clinical pharmacology.) Kazan: Meditsina. 2006; 374 p. (In Russ.)
- Glantz S.A. Mediko-biologicheskaya statistika. (Medico-biological statistics.) Moscow: Praktika. 1998; 459 p. (In Russ.)
- Sizova T.M. Statistika. (Statistics.) Saint-Petersburg: ITMO. 2005; 190 p. (In Russ.)
- Loran O.B., Segal A.S. A system of comprehensive assessment of symptoms in chronic prostatitis. Urologiya. 2001; 5: 16–19. (In Russ.)
- Urologiya: natsional'noe rukovodstvo. (Urology: the national guide.) Ed. by N.A. Lopatkin. Moscow: GEOTAR-Media. 2009; 1024 p. (In Russ.)
- Urologiya. Klinicheskie rekomendatsii. (Urology: clinical guidelines.) Ed. by N.A. Lopatkin. 2nd ed. Moscow: GEOTAR-Media. 2013; 416 p. (In Russ.)
- Integrativnaya urologiya. Rukovodstvo dlya vrachey. (Integrative urology. Guide for physicians.) Ed. by Glybochko P.V., Alyaev Yu.G. Moscow: Medforum. 2014; 432 p. (In Russ.)
- Zhirnikova M.L., Vinarov A.Z., Mashkovskiy M.D., Pytel’ Yu.A. The blockers of alpha-adrenoreceptors in therapy of patients with voiding disorders. The plenum of The Russian Society of urologists. Saratov, 1994; 88–96. (In Russ.)
- Lobkarev A.O., Khafiz’yanova R.Kh., Lobkarev O.A. Comparative study of the influence of tadalafil and doxazosin on the rate of oxygen consumption by the prostate tissue. Medicus. 2017; (4): 71–74. (In Russ.)
- Ziganshin A.U., Ziganshina L.E. P2-retseptory: perspektivnaya mishen' dlya budushchikh lekarstv. (P2-receptors: promising target for future drugs). Moscow: GEOTAR-Media. 2009; 136 p. (In Russ.)
- Ziganshin A.U., Bedova D.V., Zubkov E.A., Sitdykova M.E. P2-receptors of the urinary bladder as potential targets for novel drugs. Kazanskiy meditsinskiy zhurnal. 2018; (3): 462–466. (In Russ.)
Supplementary files
